Botox maker Allergan rejects takeover bid
Allergan, the US maker of Botox, has rejected a takeover bid from Valeant Pharmaceuticals, saying it "substantially undervalues" the company and questioning the Canadian firm's long-term growth plan.
Business
• 12 May 14